Literature DB >> 10358689

A randomized trial of breast cancer risk counseling: the impact on self-reported mammography use.

M D Schwartz1, B K Rimer, M Daly, C Sands, C Lerman.   

Abstract

OBJECTIVES: We evaluated the impact of individualized breast cancer risk counseling on mammography use among women at risk for breast cancer.
METHODS: Participants (n = 508) were randomized to the breast cancer risk counseling intervention or a general health education control intervention, and 85% completed follow-up.
RESULTS: In multivariate modeling, a significant group-by-education interaction demonstrated that among less-educated participants, breast cancer risk counseling led to reduced mammography use. There was no intervention effect among the more-educated participants.
CONCLUSIONS: These results suggest that standard breast cancer risk counseling could have an adverse impact on the health behaviors of less-educated women.

Entities:  

Mesh:

Year:  1999        PMID: 10358689      PMCID: PMC1508646          DOI: 10.2105/ajph.89.6.924

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  13 in total

1.  Screening mammography rates and barriers to use: a Los Angeles County survey.

Authors:  R Bastani; A C Marcus; A Hollatz-Brown
Journal:  Prev Med       Date:  1991-05       Impact factor: 4.018

2.  Comparison of participants and nonparticipants in a work site cancer awareness and screening program.

Authors:  E A Laville; S W Vernon; G L Jackson; J I Hughes
Journal:  J Occup Med       Date:  1989-03

Review 3.  Adherence and psychological adjustment among women at high risk for breast cancer.

Authors:  C Lerman; M Schwartz
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

4.  Recruiting high risk women into a breast cancer health promotion trial.

Authors:  C Lerman; B K Rimer; M Daly; E Lustbader; C Sands; A Balshem; A Masny; P Engstrom
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994 Apr-May       Impact factor: 4.254

Review 5.  Preventive care guidelines: 1991. American College of Physicians. Canadian Task Force on the Periodic Health Examination. United States Preventive Services Task Force.

Authors:  R S Hayward; E P Steinberg; D E Ford; M F Roizen; K W Roach
Journal:  Ann Intern Med       Date:  1991-05-01       Impact factor: 25.391

6.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.

Authors:  M H Gail; L A Brinton; D P Byar; D K Corle; S B Green; C Schairer; J J Mulvihill
Journal:  J Natl Cancer Inst       Date:  1989-12-20       Impact factor: 13.506

7.  Health Belief Model variables as predictors of screening mammography utilization.

Authors:  R B Hyman; S Baker; R Ephraim; A Moadel; J Philip
Journal:  J Behav Med       Date:  1994-08

8.  Effects of individualized breast cancer risk counseling: a randomized trial.

Authors:  C Lerman; E Lustbader; B Rimer; M Daly; S Miller; C Sands; A Balshem
Journal:  J Natl Cancer Inst       Date:  1995-02-15       Impact factor: 13.506

9.  Psychological distress and surveillance behaviors of women with a family history of breast cancer.

Authors:  K M Kash; J C Holland; M S Halper; D G Miller
Journal:  J Natl Cancer Inst       Date:  1992-01-01       Impact factor: 13.506

10.  Mammography adherence and psychological distress among women at risk for breast cancer.

Authors:  C Lerman; M Daly; C Sands; A Balshem; E Lustbader; T Heggan; L Goldstein; J James; P Engstrom
Journal:  J Natl Cancer Inst       Date:  1993-07-07       Impact factor: 13.506

View more
  19 in total

Review 1.  Genetic risk and behavioural change.

Authors:  T M Marteau; C Lerman
Journal:  BMJ       Date:  2001-04-28

Review 2.  Effects of communicating individual risks in screening programmes: Cochrane systematic review.

Authors:  Adrian Edwards; Silvana Unigwe; Glyn Elwyn; Kerenza Hood
Journal:  BMJ       Date:  2003-09-27

3.  Prospective association between distress and mammography utilization among women with a family history of breast cancer.

Authors:  Marc D Schwartz; Kathryn L Taylor; Kristen S Willard
Journal:  J Behav Med       Date:  2003-04

4.  Effects of personalized colorectal cancer risk information on laypersons' interest in colorectal cancer screening: The importance of individual differences.

Authors:  Paul K J Han; Christine W Duarte; Susannah Daggett; Andrea Siewers; Bill Killam; Kahsi A Smith; Andrew N Freedman
Journal:  Patient Educ Couns       Date:  2015-07-19

5.  Breast cancer worry among women awaiting mammography: is it unfounded? Does prior counseling help?

Authors:  Susan K Steinemann; Maria B J Chun; Dustin H Huynh; Katherine Loui
Journal:  Hawaii Med J       Date:  2011-07

6.  Breast Cancer Risk Assessment Among Low-Income Women of Color in Primary Care: A Pilot Study.

Authors:  Emily E Anderson; Silvia Tejeda; Kimberly Childers; Melinda R Stolley; Richard B Warnecke; Kent F Hoskins
Journal:  J Oncol Pract       Date:  2015-06-02       Impact factor: 3.840

7.  Development of a risk assessment tool for projecting individualized probabilities of developing breast cancer for Chinese women.

Authors:  Yuan Wang; Ying Gao; Munkhzul Battsend; Kexin Chen; Wenli Lu; Yaogang Wang
Journal:  Tumour Biol       Date:  2014-08-02

Review 8.  Risky feelings: why a 6% risk of cancer does not always feel like 6%.

Authors:  Brian J Zikmund-Fisher; Angela Fagerlin; Peter A Ubel
Journal:  Patient Educ Couns       Date:  2010-08-23

Review 9.  Personalised risk communication for informed decision making about taking screening tests.

Authors:  Adrian G K Edwards; Gurudutt Naik; Harry Ahmed; Glyn J Elwyn; Timothy Pickles; Kerry Hood; Rebecca Playle
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

10.  Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): trial protocol.

Authors:  Eleanor Mann; A Toby Prevost; Simon Griffin; Ian Kellar; Stephen Sutton; Michael Parker; Simon Sanderson; Ann Louise Kinmonth; Theresa M Marteau
Journal:  BMC Public Health       Date:  2009-02-20       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.